vimarsana.com

Latest Breaking News On - Equinox sciences - Page 6 : vimarsana.com

EyePoint Pharmaceuticals Announces Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD

/PRNewswire/ EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the.

United statesAmy phillipsChristina tartagliaEquinox sciencesPrnewswire eyepoint pharmaceuticals incEyepoint pharmaceuticals nasdaqAmerican society of retina specialistsGreen room communicationsEyepoint pharmaceuticalsEyepoint pharmaceuticals incPoint pharmaceuticalsAmerican societyRetina specialistsRishi singhStaff physicianCleveland clinic florida

EyePoint Pharmaceuticals Appoints Karen Zaderej to Board of

WATERTOWN, Mass., July 11, 2022 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and.

United statesAmy phillipsKaren zaderejChristina tartagliaEquinox sciencesPurdue universityEthicon incBoard of eyepoint pharmaceuticalsBoard at axogen incKellogg graduate school of businessEyepoint pharmaceuticals nasdaqUniversity of tampa board trusteesGreen room communicationsEyepoint pharmaceuticalsEyepoint pharmaceuticals incPoint pharmaceuticals

EyePoint Pharmaceuticals Announces Election of Tony Adamis,

WATERTOWN, Mass., June 23, 2022 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and.

United statesAmy phillipsTony adamisGenentech rocheChristina tartagliaAnthony tony adamisBoard of eyepoint pharmaceuticalsDevelopment innovationUniversity of michiganUniversity of illinoisEyepoint pharmaceuticals nasdaqUniversity of chicagoEyepoint pharmaceuticalsEyetech pharmaceuticalsEquinox sciencesDepartment of ophthalmology at harvard medical school

EyePoint Pharmaceuticals Announces Expanded License Agreement with Betta Pharmaceuticals for EYP-1901 in China, Hong Kong, Macau and Taiwan

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesHong kongAmy phillipsJinhao shenChristina tartagliaEquinox sciencesEyepoint pharmaceuticals nasdaqBetta pharmaceuticals coGreen room communicationsEyepoint pharmaceuticalsBetta pharmaceuticalsEyepoint pharmaceuticals incPoint pharmaceuticalsMainland chinaNancy lurkerChief executive officer

EyePoint Q1 net loss widens; inks license deal with China s Betta for EYP-1901

EyePoint Pharmaceuticals (EYPT) signed a license agreement with China-based Betta Pharmaceuticals to develop and commercialize EYP-1901 in Mainland China, Hong Kong, Macau and Taiwan.

Hong kongEquinox sciencesEyepoint pharmaceuticalsBetta pharmaceuticalsTrading chartsPoint pharmaceuticalsChina based betta pharmaceuticalsMainland china

vimarsana © 2020. All Rights Reserved.